BAYN Germany: Xetra


    Last Updated: Sep 9, 2022 6:30 p.m. CEDT Delayed quote


    0.96 1.85%
    Previous Close
    Advanced Charting
    Volume: 2.32M 65 Day Avg: 2.89M
    80% vs Avg
    52.25 Day Range 53.28
    43.91 52 Week Range 67.99

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    BAYN Overview

    Key Data

    • Open €52.31
    • Day Range 52.25 - 53.28
    • 52 Week Range 43.91 - 67.99
    • Market Cap €51B
    • Shares Outstanding 982.42M
    • Public Float N/A
    • Beta 0.98
    • Rev. per Employee €485.33K
    • P/E Ratio 12.25
    • EPS €4.31
    • Yield 3.78%
    • Dividend €2.00
    • Ex-Dividend Date May 2, 2022
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 2.89M


    5 Day
    • 0.46%
    1 Month
    • -2.36%
    3 Month
    • -16.82%
    • 12.49%
    1 Year
    • 15.50%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 20 Full Ratings

    Recent News

    Bayer Agrees to $40M DOJ Settlement Over Alleged Kickbacks, False Claims

    Bayer's Mirena Gets FDA Approval for Extended Use as Contraceptive

    Bayer Shares Climb After Arbitration Tribunal Dismisses BASF Claims

    Bayer Lifts 2022 Guidance But Impairments, Charges Weigh on 2Q Earnings -- Update

    Bayer Seen With Sales Jump in 2Q, Guidance Raise Expected -- Earnings Preview

    Read full story

    Why ECB Rate Hikes Risk Breaking the Euro—and Europe

    Bayer Agrees on $503 Mln Sale of Testosterone-Deficiency Drug

    Read full story

    Ray Dalio’s Bridgewater increases short bets against Europe stocks

    Bayer Says It Disagrees With U.S. Supreme Court on Roundup Decision

    Read full story

    Supreme Court rejects Bayer bid to stop Roundup lawsuits

    Bayer Wins Fourth Roundup Weedkiller Trial in US

    Read full story

    Fertilizer prices are soaring – and that’s an opportunity to promote more sustainable ways of growing crops

    Read full story

    A sticking point in China competition bill: what to do about fake products

    Read full story

    Centene CEO Michael F. Neidorff Has Died at Age 79

    Read full story

    German pharmaceuticals company Bayer condemns Russia’s ‘brutal aggression’ in Ukraine

    Read full story

    Monsanto pleads guilty to pesticide-related crimes in Hawaii

    Read full story

    Cannabis company executives saw double-digit salary gains in first quarter amid shortage of experienced workers

    Idaho farmers file antitrust lawsuit against big ag companies

    A group of farmers has filed an antitrust case against several big agricultural companies, contending the companies worked together to ban e-commerce sales in order to keep prices artificially high.

    Read full story

    U.S. COVID death toll above 518,000 as Biden adds voice to outrage at Texas and Mississippi for reopening

    Novartis agrees to help make CureVac COVID-19 vaccine

    Novartis AG and CureVac NV said Thursday they have reached an agreement for Novartis to help CureVac manufacture its COVID-19 vaccine, which is currently under review by the European Medicines Agency. Novartis expects to...

    No Headlines Available

    Bayer AG

    Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.


    Name Chg % Market Cap
    Novartis AG 0.74% CHF172.8B
    Roche Holding AG Akt 0.21% CHF266.05B
    Sanofi S.A. 0.26% €101.44B
    Eli Lilly & Co. 1.97% CHF295.72B
    Merck & Co. Inc. 0.69% €221.21B
    Pfizer Inc. 0.90% kr2.84T